Cargando…
Serological response to a third dose of SARS-CoV-2 vaccine according to previous infection history
The IgG antibody titer against SARS-CoV-2 receptor binding protein (RBD) after mRNA vaccine were compared between those with and without previous infection (PI) for up to 48 weeks. Though sustained higher IgG-RBD were observed in the PI group after two doses of vaccines, both groups benefited from t...
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022459/ https://www.ncbi.nlm.nih.gov/pubmed/36960104 http://dx.doi.org/10.1016/j.jvacx.2023.100282 |
| _version_ | 1784908735831867392 |
|---|---|
| author | Ota, Kenji Murakami, Satoshi Ishihara, Kaori Sasaki, Daisuke Usui, Tetsuya Mitsumoto-Kaseida, Fujiko Sakamoto, Kei Kosai, Kosuke Hasegawa, Hiroo Takazono, Takahiro Furumoto, Akitsugu Asoh, Norichika Yoshimine, Hiroyuki Sawai, Toyomitsu Onizuka, Masanari Makimoto, Noriaki Izumikawa, Koichi Mukae, Hiroshi Kohno, Shigeru Yanagihara, Katsunori |
| author_facet | Ota, Kenji Murakami, Satoshi Ishihara, Kaori Sasaki, Daisuke Usui, Tetsuya Mitsumoto-Kaseida, Fujiko Sakamoto, Kei Kosai, Kosuke Hasegawa, Hiroo Takazono, Takahiro Furumoto, Akitsugu Asoh, Norichika Yoshimine, Hiroyuki Sawai, Toyomitsu Onizuka, Masanari Makimoto, Noriaki Izumikawa, Koichi Mukae, Hiroshi Kohno, Shigeru Yanagihara, Katsunori |
| author_sort | Ota, Kenji |
| collection | PubMed |
| description | The IgG antibody titer against SARS-CoV-2 receptor binding protein (RBD) after mRNA vaccine were compared between those with and without previous infection (PI) for up to 48 weeks. Though sustained higher IgG-RBD were observed in the PI group after two doses of vaccines, both groups benefited from the booster shots of the third vaccine. This data supports the necessity of the booster shots to those with PI. |
| format | Online Article Text |
| id | pubmed-10022459 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100224592023-03-17 Serological response to a third dose of SARS-CoV-2 vaccine according to previous infection history Ota, Kenji Murakami, Satoshi Ishihara, Kaori Sasaki, Daisuke Usui, Tetsuya Mitsumoto-Kaseida, Fujiko Sakamoto, Kei Kosai, Kosuke Hasegawa, Hiroo Takazono, Takahiro Furumoto, Akitsugu Asoh, Norichika Yoshimine, Hiroyuki Sawai, Toyomitsu Onizuka, Masanari Makimoto, Noriaki Izumikawa, Koichi Mukae, Hiroshi Kohno, Shigeru Yanagihara, Katsunori Vaccine X Short communication The IgG antibody titer against SARS-CoV-2 receptor binding protein (RBD) after mRNA vaccine were compared between those with and without previous infection (PI) for up to 48 weeks. Though sustained higher IgG-RBD were observed in the PI group after two doses of vaccines, both groups benefited from the booster shots of the third vaccine. This data supports the necessity of the booster shots to those with PI. Elsevier 2023-03-17 /pmc/articles/PMC10022459/ /pubmed/36960104 http://dx.doi.org/10.1016/j.jvacx.2023.100282 Text en © 2023 The Author(s) |
| spellingShingle | Short communication Ota, Kenji Murakami, Satoshi Ishihara, Kaori Sasaki, Daisuke Usui, Tetsuya Mitsumoto-Kaseida, Fujiko Sakamoto, Kei Kosai, Kosuke Hasegawa, Hiroo Takazono, Takahiro Furumoto, Akitsugu Asoh, Norichika Yoshimine, Hiroyuki Sawai, Toyomitsu Onizuka, Masanari Makimoto, Noriaki Izumikawa, Koichi Mukae, Hiroshi Kohno, Shigeru Yanagihara, Katsunori Serological response to a third dose of SARS-CoV-2 vaccine according to previous infection history |
| title | Serological response to a third dose of SARS-CoV-2 vaccine according to previous infection history |
| title_full | Serological response to a third dose of SARS-CoV-2 vaccine according to previous infection history |
| title_fullStr | Serological response to a third dose of SARS-CoV-2 vaccine according to previous infection history |
| title_full_unstemmed | Serological response to a third dose of SARS-CoV-2 vaccine according to previous infection history |
| title_short | Serological response to a third dose of SARS-CoV-2 vaccine according to previous infection history |
| title_sort | serological response to a third dose of sars-cov-2 vaccine according to previous infection history |
| topic | Short communication |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022459/ https://www.ncbi.nlm.nih.gov/pubmed/36960104 http://dx.doi.org/10.1016/j.jvacx.2023.100282 |
| work_keys_str_mv | AT otakenji serologicalresponsetoathirddoseofsarscov2vaccineaccordingtopreviousinfectionhistory AT murakamisatoshi serologicalresponsetoathirddoseofsarscov2vaccineaccordingtopreviousinfectionhistory AT ishiharakaori serologicalresponsetoathirddoseofsarscov2vaccineaccordingtopreviousinfectionhistory AT sasakidaisuke serologicalresponsetoathirddoseofsarscov2vaccineaccordingtopreviousinfectionhistory AT usuitetsuya serologicalresponsetoathirddoseofsarscov2vaccineaccordingtopreviousinfectionhistory AT mitsumotokaseidafujiko serologicalresponsetoathirddoseofsarscov2vaccineaccordingtopreviousinfectionhistory AT sakamotokei serologicalresponsetoathirddoseofsarscov2vaccineaccordingtopreviousinfectionhistory AT kosaikosuke serologicalresponsetoathirddoseofsarscov2vaccineaccordingtopreviousinfectionhistory AT hasegawahiroo serologicalresponsetoathirddoseofsarscov2vaccineaccordingtopreviousinfectionhistory AT takazonotakahiro serologicalresponsetoathirddoseofsarscov2vaccineaccordingtopreviousinfectionhistory AT furumotoakitsugu serologicalresponsetoathirddoseofsarscov2vaccineaccordingtopreviousinfectionhistory AT asohnorichika serologicalresponsetoathirddoseofsarscov2vaccineaccordingtopreviousinfectionhistory AT yoshiminehiroyuki serologicalresponsetoathirddoseofsarscov2vaccineaccordingtopreviousinfectionhistory AT sawaitoyomitsu serologicalresponsetoathirddoseofsarscov2vaccineaccordingtopreviousinfectionhistory AT onizukamasanari serologicalresponsetoathirddoseofsarscov2vaccineaccordingtopreviousinfectionhistory AT makimotonoriaki serologicalresponsetoathirddoseofsarscov2vaccineaccordingtopreviousinfectionhistory AT izumikawakoichi serologicalresponsetoathirddoseofsarscov2vaccineaccordingtopreviousinfectionhistory AT mukaehiroshi serologicalresponsetoathirddoseofsarscov2vaccineaccordingtopreviousinfectionhistory AT kohnoshigeru serologicalresponsetoathirddoseofsarscov2vaccineaccordingtopreviousinfectionhistory AT yanagiharakatsunori serologicalresponsetoathirddoseofsarscov2vaccineaccordingtopreviousinfectionhistory |